Michele Visentin
Impact in
- Rheumatology top 2%
- Folate and B Vitamins Research
- Nephrology top 5%
Papers in
- Oncology 25
- Drug Transport and Resistance Mechanisms 22
- Biochemistry 10
- Amino Acid Enzymes and Metabolism 8
- Co-authors
- I. David Goldman (10 shared papers)Rongbao Zhao (9 shared papers)Gerd A. Kullak‐Ublick (28 shared papers)Zhibo Gai (23 shared papers)Ndeye Diop-Bove (2 shared papers)Sophia L. Samodelov (11 shared papers)Xianjun Fu (1 shared paper)Tianqi Wang (1 shared paper)
- Journals
- International Journal of Molecular Sciences (5 papers)Molecular Pharmacology (5 papers)Drug Metabolism and Disposition (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- SwitzerlandChinaUnited States
In The Last Decade
Michele Visentin
51 papers receiving 1.8k citations
Michele Visentin's Hit Papers
Peers
Comparison fields: 5 of 111
- Rheumatology 334
- Nephrology 129
- Clinical Biochemistry 125
- Biochemistry 131
- Molecular Medicine 80
Countries citing papers authored by Michele Visentin
This map shows the geographic impact of Michele Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Visentin more than expected).
Fields of papers citing papers by Michele Visentin
This network shows the impact of papers produced by Michele Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Visentin. The network helps show where Michele Visentin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michele Visentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lipid Accumulation and Chronic Kidney Disease Hit paper breakdown → | 2019 | 306 |
| 2 | 2011 | 284 | |
| 3 | 2012 | 195 | |
| 4 | 2011 | 158 | |
| 5 | 2019 | 116 | |
| 6 | 2018 | 80 | |
| 7 | 2020 | 64 | |
| 8 | 2017 | 64 | |
| 9 | 2016 | 44 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 34 | |
| 12 | 2011 | 32 | |
| 13 | 2017 | 30 | |
| 14 | 2019 | 28 | |
| 15 | 2019 | 25 | |
| 16 | 2015 | 23 | |
| 17 | 2018 | 21 | |
| 18 | 2018 | 19 | |
| 19 | 2012 | 19 | |
| 20 | 2016 | 19 |
About Michele Visentin
Michele Visentin is a scholar working on Oncology, Biochemistry, Rheumatology, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Folate and B Vitamins Research (9 papers), Amino Acid Enzymes and Metabolism (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Metabolism and Genetic Disorders (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Rheumatology (334 citations), Nephrology (129 citations), Clinical Biochemistry (125 citations), Biochemistry (131 citations) and Molecular Medicine (80 citations). Michele Visentin has collaborated with scholars based in Switzerland, China and United States. Frequent co-authors include I. David Goldman, Rongbao Zhao, Gerd A. Kullak‐Ublick, Zhibo Gai, Ndeye Diop-Bove, Sophia L. Samodelov, Xianjun Fu, Tianqi Wang, Zhenguo Wang and Christian Hiller. Their work appears in journals such as International Journal of Molecular Sciences, Molecular Pharmacology, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.